MRI and MRE were used to monitor the effects of immunotherapy on tumor volume, FA and biomechanics of murine orthotopic glioma. Treated tumors were significantly smaller, softer and had lower FA than controls. This difference was most pronounced when comparing tumor stiffness of both groups. Controls revealed heterogeneous tumor stiffness. We hypothesize that this is caused by viable tumor cells alternated with necrotic areas and presumably immune-suppressive iba1-positive cells. In contrast, biomechanical properties of treated animals correlated better with presence of macrophages/microglia and likely reflected anti-tumorigenic inflammation. Thus, MRE could prove useful for monitoring glioma response to therapy.
No takes yet. Share an insight, caveat, or question.
Streibel et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: